Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine.

Nakamura A, Miyamura T, Wu B, Suematsu E.

Case Rep Rheumatol. 2016;2016:5636489. doi: 10.1155/2016/5636489. Epub 2016 Jun 26.

2.

Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association Study.

Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N.

PLoS One. 2016 Jun 22;11(6):e0158065. doi: 10.1371/journal.pone.0158065. eCollection 2016.

3.

Orbital Inflammatory Pseudotumor Associated with Rheumatoid Arthritis.

Nakamura A, Miyamura T, Suematsu E.

Intern Med. 2016;55(11):1503-4. doi: 10.2169/internalmedicine.55.6408. Epub 2016 Jun 1. No abstract available.

4.

Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.

Nakashima Y, Miyahara H, Kondo M, Fukuda T, Harada H, Haraguchi A, Inoue Y, Ishinishi T, Maekawa M, Maeyama A, Nakashima M, Shono E, Suematsu E, Shimauchi T, Tsuru T, Tsukamoto H, Yoshizawa S, Yoshizawa S, Iwamoto Y.

Mod Rheumatol. 2016 May 4:1-7. [Epub ahead of print]

PMID:
27142240
5.

Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.

Hirata A, Suenaga Y, Miyamura T, Matsui T, Tohma S, Suematsu E, Ohnaka K, Takayanagi R.

Int J Rheum Dis. 2016 Apr 29. doi: 10.1111/1756-185X.12877. [Epub ahead of print]

PMID:
27126059
6.

Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.

Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N.

PLoS One. 2016 Apr 26;11(4):e0154255. doi: 10.1371/journal.pone.0154255. eCollection 2016.

7.

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease.

Nakamura A, Miyamura T, Suematsu E.

Case Rep Rheumatol. 2016;2016:1467583. doi: 10.1155/2016/1467583. Epub 2016 Mar 13.

8.

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Kitagawa K, Takahi K, Ozawa T, Hamada N, Nakajima K, Nagai H, Tamura N, Suenaga Y, Kawabata M, Matsui T, Furukawa H, Kawakami K, Oishi K.

Medicine (Baltimore). 2015 Dec;94(52):e2184. doi: 10.1097/MD.0000000000002184. Erratum in: Medicine (Baltimore). 2016 Feb;95(8):e8362. Oish, Kazunori [Corrected to Oishi, Kazunori].

9.

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Dec 10;17:357. doi: 10.1186/s13075-015-0863-3.

10.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Jun 3;17:149. doi: 10.1186/s13075-015-0662-x.

11.

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.

Ogata A, Amano K, Dobashi H, Inoo M, Ishii T, Kasama T, Kawai S, Kawakami A, Koike T, Miyahara H, Miyamoto T, Munakata Y, Murasawa A, Nishimoto N, Ogawa N, Ojima T, Sano H, Shi K, Shono E, Suematsu E, Takahashi H, Tanaka Y, Tsukamoto H, Nomura A; MUSASHI Study Investigators.

J Rheumatol. 2015 May;42(5):799-809. doi: 10.3899/jrheum.140665. Epub 2015 Apr 1.

PMID:
25834203
12.

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.

Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, Kai M, Kawabata D, Kida D, Kohsaka H, Matsumura R, Minota S, Mukai M, Sumida T, Takasugi K, Tamaki S, Takeuchi T, Ueda A, Yamamoto K, Yamanaka H, Yoshifuji H, Nomura A; Musashi Study Investigators.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1354-62. doi: 10.1002/acr.22598.

PMID:
25832859
13.

Corticoid therapy for overlapping syndromes in an HIV-positive patient.

Kaku Y, Kodama S, Higuchi M, Nakamura A, Nakamura M, Kaieda T, Takahama S, Minami R, Miyamura T, Suematsu E, Yamamoto M.

Intern Med. 2015;54(2):223-30. doi: 10.2169/internalmedicine.54.3094. Epub 2015 Jan 15.

14.

Clinical study of giant cell arteritis in our hospital.

Suematsu E, Miyamura T, Nakamura M, Higuchi M, Mori S, Iwanaga T, Kaku Y, Takahama S, Minami R, Yamamoto M.

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(6):466-72. doi: 10.2177/jsci.38.466.

15.

Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study.

Migita K, Arai T, Jiuchi Y, Izumi Y, Iwanaga N, Kawahara C, Suematsu E, Miyamura T, Tsutani H, Kawabe Y, Matsumura R, Mori S, Ohshima S, Yoshizawa S, Suenaga Y, Ogushi F, Kawabata M, Furukawa H, Matsui T, Bito S, Tohma S.

Medicine (Baltimore). 2014 Nov;93(26):e175. doi: 10.1097/MD.0000000000000175.

16.

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.

Yamada K, Oshiro Y, Okamura S, Fujisaki T, Kondo S, Nakayama Y, Suematsu E, Tamura K, Takeshita M.

Histopathology. 2015 Jul;67(1):70-80. doi: 10.1111/his.12627. Epub 2015 Feb 5.

PMID:
25429725
17.

Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.

Kawasaki A, Furukawa H, Nishida N, Warabi E, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Nagaoka S, Setoguchi K, Nagai T, Hirohata S, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Okamoto A, Kono H, Tokunaga K, Takasaki Y, Hashimoto H, Sumida T, Tohma S, Tsuchiya N.

PLoS One. 2014 Oct 6;9(10):e109764. doi: 10.1371/journal.pone.0109764. eCollection 2014.

18.

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.

Takeuchi T, Matsubara T, Urata Y, Suematsu E, Ohta S, Honjo S, Abe T, Yamamoto A, Miyasaka N; Japan Abatacept Study Group.

Mod Rheumatol. 2014 Sep;24(5):744-53. doi: 10.3109/14397595.2014.899179. Epub 2014 Apr 23.

19.

Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.

Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y.

Mod Rheumatol. 2014 Mar;24(2):258-64. doi: 10.3109/14397595.2013.854069.

PMID:
24593201
20.

Pulmonary arterial hypertension associated with IgG4-related disease.

Ishida M, Miyamura T, Sato S, Kimura D, Suematsu E.

Intern Med. 2014;53(5):493-7.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk